Comparison of Niacin Skin Flush Response in Patients with Schizophrenia and Bipolar Disorder

Authors Information
Article Notes and Dates
To Cite : Maroufi M, Tabatabaeian M, Tabatabaeian M, Mahaki B, Teimoori G. et al. Comparison of Niacin Skin Flush Response in Patients with Schizophrenia and Bipolar Disorder, Iran J Psychiatry Behav Sci. 2016 ;10(4):e504. doi: 10.17795/ijpbs-504.
Abstract
1. Introduction
2. Materials and Methods
3. Results
4. Discussion
Acknowledgements
Footnotes
References
  • 1. Siever LJ, Davis KL. The pathophysiology of schizophrenia disorders: perspectives from the spectrum. Am J Psychiatry. 2004; 161(3): 398-413[DOI][PubMed]
  • 2. Mahadik SP, Evans DR. Is schizophrenia a metabolic brain disorder? Membrane phospholipid dysregulation and its therapeutic implications. Psychiatr Clin North Am. 2003; 26(1): 85-102[PubMed]
  • 3. Fenton WS, Hibbeln J, Knable M. Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia. Biol Psychiatry. 2000; 47(1): 8-21[PubMed]
  • 4. Horrobin DF. Schizophrenia as a membrane lipid disorder which is expressed throughout the body. Prostaglandins Leukot Essent Fatty Acids. 1996; 55(1-2): 3-7[PubMed]
  • 5. Tavares H, Yacubian J, Talib LL, Barbosa NR, Gattaz WF. Increased phospholipase A2 activity in schizophrenia with absent response to niacin. Schizophr Res. 2003; 61(1): 1-6[PubMed]
  • 6. Hudson C, Gotowiec A, Seeman M, Warsh J, Ross BM. Clinical subtyping reveals significant differences in calcium-dependent phospholipase A2 activity in schizophrenia. Biol Psychiatry. 1999; 46(3): 401-5[PubMed]
  • 7. Smesny S, Volz HP, Riehemann S, Sauer H. Diseases of phospholipid metabolism as possible pathogenetic factors in schizophrenia. Current findings and critical evaluation [ in German ]. Fortschr Neurol Psychiatr. 2000; 68(7): 301-12[DOI][PubMed]
  • 8. Law MH, Cotton RG, Berger GE. The role of phospholipases A2 in schizophrenia. Mol Psychiatry. 2006; 11(6): 547-56[DOI][PubMed]
  • 9. Mahadik SP, Mukherjee S, Correnti EE, Kelkar HS, Wakade CG, Costa RM, et al. Plasma membrane phospholipid and cholesterol distribution of skin fibroblasts from drug-naive patients at the onset of psychosis. Schizophr Res. 1994; 13(3): 239-47[PubMed]
  • 10. Buretic-Tomljanovic A, Giacometti J, Nadalin S, Rubesa G, Vulin M, Tomljanovic D. Phospholipid membrane abnormalities and reduced niacin skin flush response in schizophrenia. Psychiatr Danub. 2008; 20(3): 372-83[PubMed]
  • 11. Ward PE, Sutherland J, Glen EM, Glen AI. Niacin skin flush in schizophrenia: a preliminary report. Schizophr Res. 1998; 29(3): 269-74[PubMed]
  • 12. Morrow JD, Awad JA, Oates JA, Roberts LJ. Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans. J Invest Dermatol. 1992; 98(5): 812-5[PubMed]
  • 13. Messamore E. Relationship between the niacin skin flush response and essential fatty acids in schizophrenia. Prostaglandins Leukot Essent Fatty Acids. 2003; 69(6): 413-9[PubMed]
  • 14. Chang SS, Liu CM, Lin SH, Hwu HG, Hwang TJ, Liu SK, et al. Impaired flush response to niacin skin patch among schizophrenia patients and their nonpsychotic relatives: the effect of genetic loading. Schizophr Bull. 2009; 35(1): 213-21[DOI][PubMed]
  • 15. Lien YJ, Huang SS, Liu CM, Hwu HG, Faraone SV, Tsuang MT, et al. A genome-wide quantitative linkage scan of niacin skin flush response in families with schizophrenia. Schizophr Bull. 2013; 39(1): 68-76[DOI][PubMed]
  • 16. Smesny S, Klemm S, Stockebrand M, Grunwald S, Gerhard UJ, Rosburg T, et al. Endophenotype properties of niacin sensitivity as marker of impaired prostaglandin signalling in schizophrenia. Prostaglandins Leukot Essent Fatty Acids. 2007; 77(2): 79-85[DOI][PubMed]
  • 17. Puri BK, Singh I. Normal phospholipid-related signal transduction in autism. Prog Neuropsychopharmacol Biol Psychiatry. 2002; 26(7-8): 1405-7[PubMed]
  • 18. Liu CM, Chang SS, Liao SC, Hwang TJ, Shieh MH, Liu SK, et al. Absent response to niacin skin patch is specific to schizophrenia and independent of smoking. Psychiatry Res. 2007; 152(2-3): 181-7[DOI][PubMed]
  • 19. Hudson CJ, Lin A, Cogan S, Cashman F, Warsh JJ. The niacin challenge test: clinical manifestation of altered transmembrane signal transduction in schizophrenia? Biol Psychiatry. 1997; 41(5): 507-13[PubMed]
  • 20. Ward PE. Potential diagnostic aids for abnormal fatty acid metabolism in a range of neurodevelopmental disorders. Prostaglandins Leukot Essent Fatty Acids. 2000; 63(1-2): 65-8[DOI][PubMed]
  • 21. Diagnostic and statistical manual of mental disorders. 2000;
  • 22. Frieboes RM, Moises HW, Gattaz WF, Yang L, Li T, Liu X, et al. Lack of association between schizophrenia and the phospholipase-A(2) genes cPLA2 and sPLA2. Am J Med Genet. 2001; 105(3): 246-9[PubMed]
  • 23. Nadalin S, Giacometti J, Jonovska S, Tomljanovic D, Buretic-Tomljanovic A. The impact of PLA2G4A and PTGS2 gene polymorphisms, and red blood cell PUFAs deficit on niacin skin flush response in schizophrenia patients. Prostaglandins Leukot Essent Fatty Acids. 2013; 88(2): 185-90[DOI][PubMed]
  • 24. Ruano D, Macedo A, Soares MJ, Valente J, Azevedo MH, Pato C, et al. Family-based and case-control studies reveal no association of lipocalin-type prostaglandin D2 synthase with schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2007; 144B(5): 642-6[DOI][PubMed]
  • 25. Puri BK, Hirsch SR, Easton T, Richardson AJ. A volumetric biochemical niacin flush-based index that noninvasively detects fatty acid deficiency in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2002; 26(1): 49-52[PubMed]
  • 26. Puri BK, Easton T, Das I, Kidane L, Richardson AJ. The niacin skin flush test in schizophrenia: a replication study. Int J Clin Pract. 2001; 55(6): 368-70[PubMed]
  • 27. Nilsson BM, Holm G, Hultman CM, Ekselius L. Cognition and autonomic function in schizophrenia: inferior cognitive test performance in electrodermal and niacin skin flush non-responders. Eur Psychiatry. 2015; 30(1): 8-13[DOI][PubMed]
  • 28. Messamore E. Niacin subsensitivity is associated with functional impairment in schizophrenia. Schizophr Res. 2012; 137(1-3): 180-4[DOI][PubMed]
  • 29. Smesny S, Berger G, Rosburg T, Riemann S, Riehemann S, McGorry P, et al. Potential use of the topical niacin skin test in early psychosis -- a combined approach using optical reflection spectroscopy and a descriptive rating scale. J Psychiatr Res. 2003; 37(3): 237-47[PubMed]
  • 30. Smesny S, Rosburg T, Riemann S, Baur K, Rudolph N, Berger G, et al. Impaired niacin sensitivity in acute first-episode but not in multi-episode schizophrenia. Prostaglandins Leukot Essent Fatty Acids. 2005; 72(6): 393-402[DOI][PubMed]
  • 31. Lin SH, Liu CM, Chang SS, Hwu HG, Liu SK, Hwang TJ, et al. Familial aggregation in skin flush response to niacin patch among schizophrenic patients and their nonpsychotic relatives. Schizophr Bull. 2007; 33(1): 174-82[DOI][PubMed]
  • 32. Smesny S, Rosburg T, Klemm S, Riemann S, Baur K, Rudolph N, et al. The influence of age and gender on niacin skin test results - implications for the use as a biochemical marker in schizophrenia. J Psychiatr Res. 2004; 38(5): 537-43[DOI][PubMed]
  • 33. Nadalin S, Buretic-Tomljanovic A, Rubesa G, Tomljanovic D, Gudelj L. Niacin skin flush test: a research tool for studying schizophrenia. Psychiatr Danub. 2010; 22(1): 14-27[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

Iranian Journal of Psychiatry and Behavioral Sciences accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check